Quoin Pharmaceuticals Ltd DRC (NASDAQ: QNRX) — Healthcare · Share Price, Chart & Market Data
About: Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.03 (-0.17%)
QNRXQuoin Pharmaceuticals Ltd DRC
Loading watchlist status…
Trade QNRX now
Quoin Pharmaceuticals Ltd DRC share price
QNRX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
22 Apr, 3:36 pm GMT+0
QNRX price performance
-7.088%
5D
-26.103%
1M
-57.173%
YTD
0.5%
1Y
QNRX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
22 Apr, 3:36 pm GMT+0
QNRX details
QNRX Market Signals